Liraglutide is typically dosed accordingly for T2D: Initiated at a dosage of 0.6mg per day for one week, administered subcutaneously at any time of the day, regardless of meals
10.1038/157441b0 Nature 119 RaoR
2005;63(2):S4878
Binge eating disorder (BED) is characterized by recurring episodes of uncontrollable overeating, often marked by consuming large amounts of food rapidly and to the point of discomfort
For optimal weight loss outcomes with Rybelsus, it is essential to follow a calorie-controlled diet, maintain regular physical activity, and prioritise healthy habits such as stress management and sufficient sleep
For example, a recent clinical trial found that people with stable bipolar disorder who took liraglutide lost weight, lowered A1C (a key diabetes marker), and reduced binge eating